相关实验视频

Updated: Jul 6, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K

[异质化学抗原受体T细胞的进步]

Qian Zhao1, Feng Li1

  • 1Department of Hematology,General Hospital of Eastern Theater Command of the Chinese PLA,Nanjing 210002,China.

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
|January 4, 2024
PubMed
概括

全基性CAR-T细胞疗法对血液癌症的自身治疗方法具有优势. 基因编辑策略旨在减少移植与宿主疾病,并增强抗瘤效应,以获得更好的结果.

关键词:
提前预订 提前预订一个全物质的全物质性.仿真抗原受体T细胞的T细胞受体

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

781
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.1K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529